Serum Stabilities and Antiviral Activities of Chemically Modified Peptides Against Dengue Serotypes 1–4
- 14 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 113 (3) , 587-595
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Patients Infected with CRF07_BC Have Significantly Lower Viral Loads than Patients with HIV-1 Subtype B: Mechanism and Impact on Disease ProgressionPLOS ONE, 2014
- Strategic Approaches to Optimizing Peptide ADME PropertiesThe AAPS Journal, 2014
- The emergence of peptides in the pharmaceutical business: From exploration to exploitationEuPA Open Proteomics, 2014
- Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albuminBMC Structural Biology, 2014
- Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesisNature Reviews Microbiology, 2013
- Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral PeptidesInternational Journal of Medical Sciences, 2013
- Release of Dengue Virus Genome Induced by a Peptide InhibitorPLOS ONE, 2012
- Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1BMC Infectious Diseases, 2012
- Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide AnalogsPLOS ONE, 2010
- Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory PeptidesPLOS Neglected Tropical Diseases, 2010